OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Louise Schubert, A. M. Mbekwe-Yepnang, Johanna Wassermann, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 6, pp. 1573-1581
Open Access | Times Cited: 7

Showing 7 citing articles:

Per- and polyfluoroalkyl substances (PFAS) exposure is associated with radioiodine therapy resistance and dedifferentiation of differentiated thyroid cancer
Yongchao Yu, Ning Kang, Xinyu Liu, et al.
Environmental Pollution (2025) Vol. 367, pp. 125629-125629
Closed Access | Times Cited: 1

Diagnostic value of an interpretable machine learning model based on clinical ultrasound features for follicular thyroid carcinoma
Yuxin Zheng, Yajiao Zhang, Kefeng Lu, et al.
Quantitative Imaging in Medicine and Surgery (2024) Vol. 14, Iss. 9, pp. 6311-6324
Open Access | Times Cited: 1

Current status of the prediction for radio-iodine refractory thyroid cancer: a narrative review
Yuhua Wang, Xiurong Lu, Haiyan Liu
Frontiers in Endocrinology (2024) Vol. 15
Open Access

The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC)
Dario de Biase, Andrea Repaci, Maria Concetta Nigro, et al.
Journal of Clinical & Translational Endocrinology (2024), pp. 100373-100373
Open Access

Le cancer thyroïdien différencié réfractaire à l’iode : quelle prise en charge en 2024 ?
Christine Do Cao, Antoine Danais, Paul Schwartz, et al.
Bulletin du Cancer (2024) Vol. 111, Iss. 10, pp. 10S31-10S41
Closed Access

Page 1

Scroll to top